Li X - Search Results

1

The signature genes of cuproptosis associates with tumor immune microenvironment and predicts prognosis in kidney renal clear cell carcinoma.

Liu S, Lv S, Li X, Lu W, Chen S. Liu S, et al. Among authors: li x. Front Oncol. 2024 Aug 14;14:1409620. doi: 10.3389/fonc.2024.1409620. eCollection 2024. Front Oncol. 2024. PMID: 39206152 Free PMC article.

2

Early Alpha-Fetoprotein Response Is Associated With Survival in Patients With HBV-Related Hepatocellular Carcinoma Receiving Lenvatinib.

Liu B, Shang X, Shi JY, Cui GZ, Li X, Wang NY. Liu B, et al. Among authors: li x. Front Oncol. 2022 Feb 17;12:807189. doi: 10.3389/fonc.2022.807189. eCollection 2022. Front Oncol. 2022. PMID: 35251977 Free PMC article.

3

Comparison analysis of PD-1/PD-L1 inhibitors plus lenvatinib or gemcitabine/cisplatin as first-line treatment for patients with advanced intrahepatic cholangiocarcinoma.

Huang JX, Liu B, Li Y, Li X, Ding LJ, Wang NY. Huang JX, et al. Among authors: li y, li x. Front Oncol. 2023 Aug 18;13:1204486. doi: 10.3389/fonc.2023.1204486. eCollection 2023. Front Oncol. 2023. PMID: 37664019 Free PMC article.

4

Tree shrews as a new animal model for systemic sclerosis research.

Zheng L, Chen S, Wu Q, Li X, Zeng W, Dong F, An W, Qin F, Lei L, Zhao C. Zheng L, et al. Among authors: li x. Front Immunol. 2024 Jan 26;15:1315198. doi: 10.3389/fimmu.2024.1315198. eCollection 2024. Front Immunol. 2024. PMID: 38343538 Free PMC article.

5

A novel LINC02321 promotes cell proliferation and decreases cisplatin sensitivity in bladder cancer by regulating RUVBL2.

Lu C, Gao H, Li H, Luo N, Fan S, Li X, Deng R, He D, Zhao H. Lu C, et al. Among authors: li h, li x. Transl Oncol. 2024 Jul;45:101962. doi: 10.1016/j.tranon.2024.101962. Epub 2024 Apr 26. Transl Oncol. 2024. PMID: 38677015 Free PMC article.

6

Cardiovascular adverse events associated with immune checkpoint inhibitors: a meta-analysis.

Li X, Li D. Li X, et al. Among authors: li d. Front Immunol. 2024 Jun 24;15:1394123. doi: 10.3389/fimmu.2024.1394123. eCollection 2024. Front Immunol. 2024. PMID: 38979409 Free PMC article.

7

Intraoperative radiotherapy might not serve as a standard therapy for retroperitoneal liposarcoma: insights from a population-based propensity score-matched study.

Zhou X, Zhuang A, Li X, Xi Z, Cheng Y, Yan G, Wang Y, Zhang G, Huang Y, Zhang C, Xie F, Ma X, Wu T, Li W. Zhou X, et al. Among authors: li w, li x. Front Oncol. 2024 Oct 25;14:1431920. doi: 10.3389/fonc.2024.1431920. eCollection 2024. Front Oncol. 2024. PMID: 39525625 Free PMC article.

8

Adverse event profile of lorazepam: a real-world pharmacovigilance study using the FDA adverse event reporting system database.

Su Z, Huang Z, Chen X, Li X. Su Z, et al. Among authors: li x. Front Pharmacol. 2024 Nov 22;15:1465245. doi: 10.3389/fphar.2024.1465245. eCollection 2024. Front Pharmacol. 2024. PMID: 39650163 Free PMC article.

9

The new era of lung cancer therapy: Combining immunotherapy with ferroptosis.

Li Y, Tuerxun H, Zhao Y, Liu X, Li X, Wen S, Zhao Y. Li Y, et al. Among authors: li x. Crit Rev Oncol Hematol. 2024 Jun;198:104359. doi: 10.1016/j.critrevonc.2024.104359. Epub 2024 Apr 12. Crit Rev Oncol Hematol. 2024. PMID: 38615871 Review.

10

Radiotherapy and surgery remain effective treatment options for retroperitoneal MPNST: a retrospective study based on SEER database.

Xi Z, Aobo Z, Li X, Yue W, Yan G, Lin Z, Zhang G, Xia X, Lian L, Li W. Xi Z, et al. Among authors: li w, li x. Front Surg. 2024 May 30;11:1339170. doi: 10.3389/fsurg.2024.1339170. eCollection 2024. Front Surg. 2024. PMID: 38872723 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183,851 results

Search Page

Filters